Penn Medicine Identifies New Biomarkers, Targeted Treatments for Sarcoidosis
September 04, 2024
September 04, 2024
UNIVERSITY CITY, Pennsylvania, Sept. 4 (TNSres) -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
* * *
Researchers find that existing FDA-approved medications can target receptor
* * *
PHILADELPHIA - Sarcoidosis is a rare systemic disease that afflicts an estimated 200,000 people in the US, more often people who are Black and more women than men, particularly when it causes chronic skin dis . . .
* * *
Researchers find that existing FDA-approved medications can target receptor
* * *
PHILADELPHIA - Sarcoidosis is a rare systemic disease that afflicts an estimated 200,000 people in the US, more often people who are Black and more women than men, particularly when it causes chronic skin dis . . .